torcetrapib has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krumholz, HM; Lee, TH | 1 |
| Tan, KC | 1 |
| Gore, MO; McGuire, DK | 1 |
| Barter, PJ; Boekholdt, SM; Breazna, A; Kastelein, JJ; Rye, KA; Tardif, JC; Waters, DD | 1 |
2 review(s) available for torcetrapib and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Reverse cholesterol transport in type 2 diabetes mellitus.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; ATP-Binding Cassette Transporters; Biological Transport; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Diabetes Mellitus, Type 2; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins, HDL; Liver; Liver X Receptors; Mice; Niacin; Orphan Nuclear Receptors; Peroxisome Proliferator-Activated Receptors; Quinolines; Rabbits; Scavenger Receptors, Class B; Thiazolidinediones | 2009 |
Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs.
Topics: Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Quinolines; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2009 |
1 trial(s) available for torcetrapib and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.
Topics: Aged; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glycated Hemoglobin; Heptanoic Acids; Homeostasis; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Prospective Studies; Pyrroles; Quinolines | 2011 |
1 other study(ies) available for torcetrapib and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Redefining quality--implications of recent clinical trials.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Quality of Health Care; Quinolines; Risk Factors | 2008 |